TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN

Agonists for TLR9 and Stimulator of IFN Gene (STING) act as vaccine adjuvants that induce type-1 immune responses. However, currently available CpG oligodeoxynucleotide (ODN) (K-type) induces IFNs only weakly and STING ligands rather induce type-2 immune responses, limiting their potential therapeut...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Immunol
Auteurs principaux: Temizoz, Burcu, Kuroda, Etsushi, Ohata, Keiichi, Jounai, Nao, Ozasa, Koji, Kobiyama, Kouji, Aoshi, Taiki, Ishii, Ken J
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2015
Sujets:
Innate Immunity
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671267/
https://ncbi.nlm.nih.gov/pubmed/25529558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201445132
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires